Cargando…

The potential risks of C-C chemokine receptor 5-edited babies in bone development

Detalles Bibliográficos
Autores principales:	Xie, Yong, Zhan, Shaohua, Ge, Wei, Tang, Peifu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351561/ https://www.ncbi.nlm.nih.gov/pubmed/30701110 http://dx.doi.org/10.1038/s41413-019-0044-0

Ejemplares similares

Agreements and disagreements regarding “shaken baby syndrome”
por: Lynøe, Niels, et al.
Publicado: (2022)

Open questions: why are babies rarely born with cancer?
por: Monje, Michelle
Publicado: (2018)

Potentials of C‐C motif chemokine 2–C‐C chemokine receptor type 2 blockers including propagermanium as anticancer agents
por: Yumimoto, Kanae, et al.
Publicado: (2019)

Unchain my heart, baby let me go—the entry and intracellular transport of HIV
por: Sodeik, Beate
Publicado: (2002)

RNA-editing in Basidiomycota, revisited
por: Min, Byoungnam, et al.
Publicado: (2021)

C–C chemokine receptor 5 and acute graft‐versus‐host disease
por: Yuan, Jing, et al.
Publicado: (2022)

C-C Chemokine Receptor 7 in Cancer
por: Bill, Colin A., et al.
Publicado: (2022)

Identification of C-C Chemokine Receptor 1 (CCR1) as the Monocyte Hemofiltrate C-C Chemokine (HCC)-1 Receptor
por: Tsou, Chia-Lin, et al.
Publicado: (1998)

IL-1 receptor antagonist, MIS-C, and the peculiar autoimmunity of SARS-CoV-2
por: Bassiri, Hamid, et al.
Publicado: (2022)

Role Of The C-C Motif Chemokine Ligand 5 (CCL5) And Its Receptor, C-C Motif Chemokine Receptor 5 (CCR5) In The Genesis Of Aldosterone-induced Hypertension, Vascular Dysfunction, And End-organ Damage
por: Costa, Rafael M., et al.
Publicado: (2023)

Progress in genomics according to bingo: 2013 edition
por: Karczewski, Konrad J
Publicado: (2013)

Genome editing: progress and challenges for medical applications
por: Carroll, Dana
Publicado: (2016)

Babies before bottom lines: A call for Australia to end exploitative marketing of commercial milk formula at home and abroad
por: Munzer, Madeleine, et al.
Publicado: (2022)

Targeting C–C Chemokine Receptor 5: Key to Opening the Neurorehabilitation Window After Ischemic Stroke
por: Feng, Yi-Qi, et al.
Publicado: (2022)

Comment on Geoffroy, M.-C.; de Thé, H. Classic and Variants APLs, as Viewed from a Therapy Response. Cancers 2020, 12, 967
por: Su, Zhan, et al.
Publicado: (2021)

Complement C5a inhibition: a new form of COVID-19 treatment for mechanically ventilated patients?
por: Kalil, Andre C, et al.
Publicado: (2022)

Improving outcomes for First Nations mothers and babies in Australia through culturally safe continuity of midwifery care: the time for scale-up is now!
por: McLachlan, Helen, et al.
Publicado: (2023)

p53 activation: a checkpoint for precision genome editing?
por: Conti, Anastasia, et al.
Publicado: (2018)

Comment on “Endothelial Protein C Receptor (EPCR), Protease Activated Receptor-1 (PAR-1) and Their Interplay in Cancer Growth and Metastatic Dissemination” Cancers 2019, 11, 51
por: Pontarollo, Giulia, et al.
Publicado: (2019)

Chemokines and chemokine receptors in Behçet’s disease
por: Li, Zhan, et al.
Publicado: (2023)

Cas9 immunity creates challenges for CRISPR gene editing therapies
por: Crudele, Julie M., et al.
Publicado: (2018)

Lead Screening for HIV of C-C Chemokine Receptor Type 5 Receptor Inhibited by Traditional Chinese Medicine
por: Hung, Tzu-Chieh, et al.
Publicado: (2014)

Addressing fundamental questions on MIS-C
por: Davies, Patrick
Publicado: (2021)

Stimulation of osteoclast migration and bone resorption by C–C chemokine ligands 19 and 21
por: Lee, Jiyeon, et al.
Publicado: (2017)

Chemokine (C-X-C motif) receptor 4 RNA interference inhibits bone metastasis in breast cancer
por: ZENG, HENG, et al.
Publicado: (2014)

Meta-analysis of the prognostic value of C-C chemokine receptor type 7 in patients with solid tumors
por: Zu, Guangchen, et al.
Publicado: (2019)

C-C chemokine receptor type five (CCR5): An emerging target for the control of HIV infection()
por: Barmania, Fatima, et al.
Publicado: (2013)

The Membrane-Proximal Region of C–C Chemokine Receptor Type 5 Participates in the Infection of HIV-1
por: Tan, Yue, et al.
Publicado: (2017)

C-C chemokine receptor 5 signaling contributes to cardiac remodeling and dysfunction under pressure overload
por: Wang, Xiaomin, et al.
Publicado: (2021)

The roles of bone‐derived exosomes and exosomal microRNAs in regulating bone remodelling
por: Xie, Yong, et al.
Publicado: (2016)

Comment on Hurley, J.C. Towards Clinical Application of Anti-endotoxin Antibodies; A Re-Appraisal of the Disconnect. Toxins 2013, 5, 2589-2620
por: Brock-Utne, John G.
Publicado: (2014)

Can community pharmacists treat hepatitis C virus?
por: Wade, Amanda J
Publicado: (2020)

Cloning and functional characterization of the rabbit C-C chemokine receptor 2
por: Lu, Deshun, et al.
Publicado: (2005)

The C-C Chemokine Receptor Type 4 Is an Immunomodulatory Target of Hydroxychloroquine
por: Beck, Tyler C., et al.
Publicado: (2020)

Evaluation of C-C Chemokine Ligand 5 (CCL5) Chemokine, Interleukin 5 (IL-5) Cytokine, and Eosinophil Counts as Potential Biomarkers in Saudi Patients with Chronic Asthma During Sandstorms
por: Alturaiki, Wael H
Publicado: (2020)

Impacts of Chemokine (C-X-C Motif) Receptor 2 C1208T Polymorphism on Cancer Susceptibility
por: Zhou, Jing, et al.
Publicado: (2021)

Comment on McCarthy, C.; et al. Developing Picornaviruses for Cancer Therapy. Cancers 2019, 11, 685
por: Alberts, Pēteris
Publicado: (2020)

An Assessment of GUCA1C Variants in Primary Congenital Glaucoma
por: Souzeau, Emmanuelle, et al.
Publicado: (2021)

Steroids or intravenous immunoglobulin as first line in MIS-C in LMICs
por: Crosby, Laura, et al.
Publicado: (2021)

Data from the MOSAiC Arctic Ocean drift experiment
por: Frickenhaus, Stephan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ubt6f7f8otvhl05tjfq6d9jfnk